ALDX icon

Aldeyra Therapeutics
ALDX

Overview Fund Activity

96 hedge funds and large institutions have $232M invested in Aldeyra Therapeutics in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 36 reducing their positions, and 10 closing their positions.

Holders
96
Holders Change
+7
Holders Change %
+7.87%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
18
Increased
24
Reduced
36
Closed
10
Calls
$1.53M
Puts
$2.61M
Net Calls
-$1.08M
Net Calls Change
-$137K

Top Buyers

1
JGC
1
J. Goldman & Co
New York
$4.57M
2
EAM
2
Eagle Asset Management
Florida
$12.3M
3
Millennium Management
3
Millennium Management
New York
$5.92M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$2.25M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1.71M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$4.94M
2
Verition Fund Management
2
Verition Fund Management
Connecticut
$10.8M
3
6CM
3
683 Capital Management
New York
$205K
4
TCM
4
Tang Capital Management
California
$1.9M
5
PM
5
Prosight Management
Texas
$5.98M
Name Holding Trade Value Shares
Change 		Shares
Change %
CWM
101
Curi Wealth Management
North Carolina
– -$115K -21,500 Closed
VF
102
Virtu Financial
New York
– -$99K -18,573 Closed
KAS
103
Kestra Advisory Services
Texas
– -$92K -17,138 Closed
AGM
104
Alpine Global Management
New York
– -$64K -12,025 Closed
TRCT
105
Tower Research Capital (TRC)
New York
– -$36K -6,754 Closed
1 2 3 4
5